| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/18/2013 | US20130096049 Therapeutic conjugates |
| 04/18/2013 | US20130095569 Pregnancy-associated plasma protein-a2 (papp-a2) polynucleotides |
| 04/18/2013 | US20130095549 Tweak receptor |
| 04/18/2013 | US20130095482 Methods of detecting pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/18/2013 | US20130095475 Genes from the 20q13 amplicon and their uses |
| 04/18/2013 | US20130095193 Compounds useful as inhibitors of atr kinase |
| 04/18/2013 | US20130095182 Methods And Formulations For Modulating Lyn Kinase Activity And Treating Related Disorders |
| 04/18/2013 | US20130095181 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof |
| 04/18/2013 | US20130095178 Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same |
| 04/18/2013 | US20130095143 Biomaterial from wharton's jelly umbilical cord |
| 04/18/2013 | US20130095140 Biguanide Compositions and Methods of Treating Metabolic Disorders |
| 04/18/2013 | US20130095127 METHODS OF INHIBITING INFLAMMATION AND INFLAMMATORY DISEASES USING Gal-3BP (BTBD17B, LGALS3BP, GALECTIN-3 BINDING PROTEIN, MAC-2 BINDING PROTEIN) |
| 04/18/2013 | US20130095126 Use of substituted heterocyclic compounds to control sea lice on fish |
| 04/18/2013 | US20130095125 Palatinose for enhancing dietary supplement and pharmaceutical delivery |
| 04/18/2013 | US20130095123 New binder-drug conjugates (ADCs) and use thereof |
| 04/18/2013 | US20130095117 Therapeutic uses of inhibitors of rtp801 |
| 04/18/2013 | US20130095109 Antibody polypeptides that antagonize cd40l |
| 04/18/2013 | US20130095108 Factor xii inhibitors for treating interstitial lung disease |
| 04/18/2013 | US20130095103 Means and methods for the treament of tumorous diseases |
| 04/18/2013 | US20130095101 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |
| 04/18/2013 | US20130095100 Heterocyclic kinase inhibitors |
| 04/18/2013 | US20130095098 Pd-1 antibody |
| 04/18/2013 | US20130095092 Recombinant human naglu protein and uses thereof |
| 04/18/2013 | US20130095082 Use of des-aspartate-angiotensin i in inflammation-related pathologies and diseases |
| 04/18/2013 | US20130095069 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 04/18/2013 | US20130095067 Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae |
| 04/18/2013 | US20130095066 Compounds for the Treatment of Hepatitis C |
| 04/18/2013 | US20130095062 Recombinant production of authentic human proteins using human cell expression systems |
| 04/18/2013 | US20130095046 Method And Composition For Improving Skin Barrier Function |
| 04/18/2013 | US20130095034 Anti-CD74 Immunoconjugates and Methods |
| 04/18/2013 | US20130095032 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 04/18/2013 | DE112011102356T5 Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von Erkrankungen oder Zuständen, die mit dem Herz-Kreislauf-System in Verbindung stehen A pharmaceutical combination compositions and methods for treating diseases or conditions associated with the cardiovascular system |
| 04/18/2013 | CA2851751A1 Compositions for the treatment of rheumatoid arthritis and methods of using same |
| 04/18/2013 | CA2851383A1 2 - carboxamide cycloamino urea derivatives in combination with hsp90 inhibitors for the treatment of proliferative diseases |
| 04/18/2013 | CA2850575A1 Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy |
| 04/17/2013 | EP2581091A1 Use of inhaled nitrous oxide or xenon for preventing neuropathic pain induced by cancer chemotherapy |
| 04/17/2013 | EP2581090A1 Glycosaminoglycan oral use and compositions |
| 04/17/2013 | EP2581083A1 Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents |
| 04/17/2013 | EP2580240A1 S100a4 antibodies and therapeutic uses thereof |
| 04/17/2013 | EP2579716A1 Novel prolylcarboxypeptidase inhibitors |
| 04/17/2013 | EP2579715A1 Applications of partially and fully sulfated hyaluronan |
| 04/17/2013 | CN103052882A Method for screening chronic inflammation suppression agent or cancer metastasis suppression agent having inhibition of bonding of emmprin and s100a9 as indicator |
| 04/17/2013 | CN103052404A Neuropilin as a biomarker for bevacizumab combination therapies |
| 04/17/2013 | CN103052387A Pharmaceutical composition containing a tryptophan derivative |
| 04/17/2013 | CN103046158A Spinning solution, nuclear shell nanofiber as well as preparation method and application thereof |
| 04/17/2013 | CN103041406A Method for preparing diagnosis and treatment-cooperated nano particles release system by template method |
| 04/17/2013 | CN103041402A Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation |
| 04/17/2013 | CN103041393A Preparation method of nano multi-medicine medicine carrying system for treating cancer |
| 04/17/2013 | CN103041392A Composition of oryzanol and proton pump inhibitor |
| 04/17/2013 | CN103041391A Biguanide and probucol composition medicament for treating nonalcoholic fatty liver disease |
| 04/17/2013 | CN103041390A Melbine and ezetimibe combined composition medicament for treating nonalcoholic fatty liver disease |
| 04/17/2013 | CN103041389A Treating psychological conditions using muscarinic receptor m1 antagonists |
| 04/17/2013 | CN103040859A Use of inhaled nitrous oxide or xenon for preventing neuropathic pain induced by cancer chemotherapy |
| 04/17/2013 | CN103040768A Powder mixing technology for compound antibiotic |
| 04/17/2013 | CN103040757A Core-shell drug nano-particles, as well as preparation method and application thereof |
| 04/17/2013 | CN103040755A APARPAR polypeptide-modified invisible liposome and drug delivery system |
| 04/17/2013 | CN103040727A Preparation method of drug and protein sustained-release alginate hybrid gel |
| 04/17/2013 | CN102302668B Pharmaceutical composition for treating polycystic ovary syndrome (PCOS) |
| 04/17/2013 | CN102038641B Preparation method of liposome medicine with outer layer modified by hydrophilic polymer |
| 04/17/2013 | CN102016163B Feeding system comprising parallel pumps and individual flows for a digester |
| 04/17/2013 | CN101653431B Oral mucosa medicament slow release preparation for treating oral periodontal disease and preparation thereof |
| 04/16/2013 | US8420600 Relieving pain at a body site by administering a dosage of capsaicinoid at the painful site without eliciting an effect outside the discrete location; local anesthetic effect; targeted therapy |
| 04/16/2013 | CA2538755C Granular jelly drink capable of masking bitterness |
| 04/16/2013 | CA2527722C Biodegradable poly(beta-amino esters) and uses thereof |
| 04/16/2013 | CA2478169C Human antibodies specific to kdr and uses thereof |
| 04/16/2013 | CA2476846C Method for detection of leptin receptor ligands |
| 04/16/2013 | CA2465973C Posh nucleic acids, polypeptides and related methods |
| 04/11/2013 | WO2013052760A1 Compositions for the treatment of dry eye |
| 04/11/2013 | WO2013051389A1 Medicinal agent responsive to metal salen complex compound, and system for controlling in vivo behavior of metal salen complex compound |
| 04/11/2013 | WO2013050422A1 Reactivation of hiv-1 gene expression to treat persistent hiv infection |
| 04/11/2013 | WO2013026558A3 Combined therapeutic agent |
| 04/11/2013 | WO2013009521A3 Methods and compositions for treating asthma using anti-il-13 antibodies |
| 04/11/2013 | WO2012129145A8 Nsclc combination therapy |
| 04/11/2013 | WO2001027079A3 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/11/2013 | US20130091591 Artery- and vein-specific proteins and uses therefor |
| 04/11/2013 | US20130090388 Method of treating gaucher disease |
| 04/11/2013 | US20130090386 Lysine specific demethylase-1 inhibitors and their use |
| 04/11/2013 | US20130090371 Methods and compositions for inhibition of beta2-adrenergic receptor degradation |
| 04/11/2013 | US20130090346 Use of 1H-quinazoline-2,4-diones |
| 04/11/2013 | US20130090342 Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
| 04/11/2013 | US20130090324 Novel prolylcarboxypeptidase inhibitors |
| 04/11/2013 | US20130090312 Methods of use related to xerostomia |
| 04/11/2013 | US20130090309 Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors |
| 04/11/2013 | US20130090307 Baclofen and acamprosate based therapy of neurological disorders |
| 04/11/2013 | US20130090299 Phosphonate analogs of hiv inhibitor compounds |
| 04/11/2013 | US20130090296 Injectable formulation of a macrocyclic lactone and levamisole |
| 04/11/2013 | US20130090292 Treatment of degenerative joint disease |
| 04/11/2013 | US20130089927 Hematopoietic Cell E-Selectin/L-Selectin Ligand Polypeptides and Methods of Use Thereof |
| 04/11/2013 | US20130089625 Compounds Useful as Inhibitors of ATR Kinase |
| 04/11/2013 | US20130089560 Bone morphogenetic protein receptor binding agents and methods of their use |
| 04/11/2013 | US20130089545 Novel compounds and their effects on feeding behaviour |
| 04/11/2013 | US20130089544 Antibodies Directed to ERBB2 |
| 04/11/2013 | US20130089538 Treating cancer by modulating mammalian sterile 20-like kinase 3 |
| 04/11/2013 | US20130089537 Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42 |
| 04/11/2013 | US20130089518 Novel pyrimidine derivatives |
| 04/11/2013 | CA2851398A1 Compositions for the treatment of dry eye |
| 04/10/2013 | EP2578588A1 Novel 1,4-diazepam pde-5 inhibitor derivatives |
| 04/10/2013 | EP2578233A1 Therapeutic agent for pancreatic cancer |
| 04/10/2013 | EP2578213A1 Treatment of oral pharyngeal dysphagia |
| 04/10/2013 | EP2576535A1 Combination cancer therapies with wortmannin analogs |